Login
$XRTX
$0.99 -$0.05 (4.87%) After hours

Ownership

13F as of Q2 2026 · 7.0M shares outstanding

Who owns XRTX?

By type of holder
Institutions 0.0% Everyone else 100.0%

No insider has reported a holding in the last two years, so insiders are counted in "Everyone else".

Institutional ownership
0.0%
0.0 pts vs last qtr
Institutional holders
0
-1 vs last qtr
Net shares bought
−47
by institutions in Q2 2026
New / sold out
0 / 1
positions opened vs closed

How is ownership changing?

Institutions, last 8 quarters

Biggest buyers in Q2 2026

None.

Biggest sellers in Q2 2026
  • TD Waterhouse Canada Inc. SOLD OUT −47

Who is planning to sell?

No insider has filed a notice of proposed sale (Form 144) for XORTX Therapeutics Inc. in the last 12 months.

Is your stake being diluted?

Diluted share count, FY2021–FY2025
+332.7%
+44.23% a year
Each share's claim on the business
−76.9%
shrank without buying or selling a share
Spent on buybacks vs paid in stock
— vs $1.15M
over 5 fiscal years
Diluted shares, split-adjusted
1.1M2.9M4.8M2021: 1.1M shares'212022: 1.5M shares'222023: 2.0M shares'232024: 2.9M shares'242025: 4.7M shares'25
Buybacks Stock-based comp
$0$244.0K$487.9K2021 buybacks: $02021 stock comp: $396.4K'212022 buybacks: $02022 stock comp: $487.9K'222023 buybacks: $02023 stock comp: $121.0K'232024 buybacks: $02024 stock comp: $122.5K'242025 buybacks: $02025 stock comp: $25.2K'25

How patient are the owners?

No 13F manager reports holding XRTX.

Super Investors

Investment managers reporting XRTX on Form 13F
TW
TD Waterhouse Canada Inc.
Shares
—
% of company
—
Change vs last qtr
SOLD OUT
Held since
—

Institutional Funds

Mutual funds and ETFs reporting XRTX on Form N-PORT; together they hold 0.0% of the company
No fund reports holding XRTX yet.

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support